<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr81-1759720X20912646">
 <label>81</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Watanabe</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fukae</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Fukaya</surname>
    <given-names>S</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs</article-title>. 
  <source>Int J Rheum Dis</source>
  <year>2019</year>; 
  <volume>22</volume>: 
  <fpage>574</fpage>â€“
  <lpage>582</lpage>.
  <pub-id pub-id-type="pmid">30338649</pub-id>
 </mixed-citation>
</ref>
